| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/06/2001 | US6184036 Ornithine biosynthesis enzymes |
| 02/06/2001 | US6184034 Deoxyribonuclease II proteins and cDNAS |
| 02/06/2001 | US6184032 Identification of genes encoding cell surface antigens using CREF-Trans 6 cells |
| 02/06/2001 | US6184031 DNA sequences that encode a natural resistance to infection with intracellular parasites |
| 02/06/2001 | US6184026 Preparing defective cells which produces preferential heterologous proteins; propagate trichoderma cells, detect cells with defective propagation phenotype, detect cells which are secreting preferential heterologous protein |
| 02/06/2001 | US6184025 Nucleotide sequences for the detection and diagnosis of viral diseases |
| 02/06/2001 | US6184022 Membrame matrix enzymatic protein; for use in the diagnosis and of tumors |
| 02/06/2001 | US6184020 Polypeptides having aminopeptidase activity and nucleic acids encoding same |
| 02/06/2001 | US6184019 Cellulases, the genes encoding them and uses thereof |
| 02/06/2001 | US6184018 β-glucosidase coding sequences and protein from orpinomyces PC-2 |
| 02/06/2001 | US6184016 Polypeptides having prenylcysteine carboxyl methyltransferase activity or inhibiting activity |
| 02/06/2001 | US6184012 Isolation of enzymes |
| 02/06/2001 | US6184007 Method for the fermentative production of D-pantothenic acid by enhancement of the panD gene in microorganisms |
| 02/06/2001 | US6184006 Transforming vector containing gene for aspartate-1-decarboxyase into enterobacteriaceae, culturing to produce pantothenic acid in medium, and recovering |
| 02/06/2001 | US6184000 Directional insertion of dna sequences into a vector by using restriction sites and inserts; for multi-gene expression vectors and cassettes |
| 02/06/2001 | US6183999 Restricting sensitivity of polymerase chain reaction so that only parvovirus concentrations greater than specific threshold point are detected; processing blood for transfusions |
| 02/06/2001 | US6183998 Modified thermostable dna polymerase which has been deactivated by crosslinking with an aldehyde under aqueous conditions; enzyme can be activated by heating; for use in polymerase chain reactions |
| 02/06/2001 | US6183996 Nucleotide sequence encoding carbamoyl phosphate synthetase II |
| 02/06/2001 | US6183995 Methods of measuring gene expression using wax-embedded tissue specimens |
| 02/06/2001 | US6183993 Complement-resistant non-mammalian DNA viruses and uses thereof |
| 02/06/2001 | US6183992 Recombinant production by constructing and using expression vector having fusion gene coding for negatively charged acidic peptide with two cysteines and positively charged basic antimicrobial peptide; minimizes effect of microbiocide |
| 02/06/2001 | US6183991 Nucleotide and amino acid sequence; recombinant production of polypeptide; enhancing viability of cryopreserved sperm, sperm motility, and fertilization in assisted reproduction; contraceptives |
| 02/06/2001 | US6183990 Compounds |
| 02/06/2001 | US6183989 Process for making desired polypeptides in yeast |
| 02/06/2001 | US6183988 Leukocyte-specific protein and gene, and methods of use thereof |
| 02/06/2001 | US6183987 Transfecting insect cell with nucleic acids encoding subunits of hormone where one of the nucleic acids contains a sequence having destabilizing effect on untranslated region of messenger rna, culturing, and recovering |
| 02/06/2001 | US6183986 OspA DNA and lyme disease vaccine |
| 02/06/2001 | US6183985 Transformed yeast host cell includes expression cassette coding for protein using regulatory sequences from alcohol dehydrogenase and glyceraldehyde-3-phosphate dehydrogenase genes and expression cassette which codes for adr i |
| 02/06/2001 | US6183984 Sequences for promoting epidermal cell-specific transcription |
| 02/06/2001 | US6183976 Isolated polypeptide of defined amino acid sequence having immunogenic portion of babesia microti antigen; vaccines; immunoassay detection |
| 02/06/2001 | US6183974 Transfecting specific cells which express urokinase plasminogen activator and have suppressed gs signaling of enzyme with expression vector coding for g protein coupled receptor, contacting with compound, measuring enzyme activity |
| 02/06/2001 | US6183970 Polynucleotide probe chip and polynucleotide detection method |
| 02/06/2001 | US6183969 Genetically engineering eukaryotic cell with marker gene having breakage site in intron; causing breakage; detecting cells which repair by rearrangement; isolating dna; analyzing as nonhomologous translocation, inversion, deletion,insertion |
| 02/06/2001 | US6183966 Using database of stability values for independent combinations of nearest-neighbor nucleic acid base pairs, a computer, and a program to identify nucleotide sequence capable of targeting a gene; gene therapy |
| 02/06/2001 | US6183965 Modulating expression of target gene in recombinant cell using low molecular weight (less than 5 kilodaltons), membrane permeable compounds |
| 02/06/2001 | US6183962 Nucleotide sequence of cardiovascular system associated protein kinase; antisense agents; recombinant expression vectors; host cells for culture production; diagnosis and treatment of cardiovascular disorders; probes; primers; kits |
| 02/06/2001 | US6183959 Identifying nucleic acid catalyst which modifies a biological system by introducing random library of catalysts into system then determining sequence of portion of substrate binding domain from system which has been modified |
| 02/06/2001 | US6183957 Method for isolating a polynucleotide of interest from the genome of a mycobacterium using a BAC-based DNA library application to the detection of mycobacteria |
| 02/06/2001 | US6183955 Methods for determining the coat color genotype of a pig |
| 02/06/2001 | US6183953 Multistep process by introducing linear dna construct including altered segment of target chromosomal locus and selectable marker, culturing to determine homologous recombination, culturing to determine presence of marker |
| 02/06/2001 | US6183755 These proteins can be used to produce specific and sensitive diagnostic assay kits. the specific combination of the immunologically active proteins makes precise diagnosis possible. |
| 02/06/2001 | US6183754 Anticytomegalovirus monoclonal antibodies and processes for the in vitro diagnosis of infections by human cytomegaloviruses and a protein-kinase inducible by cytomegaloviruses and recognizable by aforesaid monoclonal antibodies |
| 02/06/2001 | US6183753 Recombinant chimeric virus and uses thereof |
| 02/06/2001 | US6183752 Gene expression of exogenous epitope of cytomegalo virus; genetic engineering |
| 02/06/2001 | US6183751 Unique associated Kaposi's Sarcoma virus sequences and uses thereof |
| 02/06/2001 | US6183750 Vaccines; gene expression |
| 02/06/2001 | US6183740 Recombinant bacterial phytases and uses thereof |
| 02/06/2001 | US6183739 Phospholipases in animal feed |
| 02/06/2001 | US6183735 Immortalized retinal pigmentary epithelial cell lines and their applications |
| 02/06/2001 | US6183734 Inhibition of tumor cell growth by administration of B7-transfected cells |
| 02/06/2001 | US6183121 Computer for producing a three-dimensional representation of a molecule or complex of a binding pocket of given structure coordinates and amino acid residues; computer model for designing possible antagonists or agonists of helicase |
| 02/06/2001 | CA2181190C Mesoscale sample preparation device and systems for determination and processing of analytes |
| 02/06/2001 | CA2125467C Process for producing hydrophobic polypeptides, proteins or peptides |
| 02/06/2001 | CA2106299C Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 02/06/2001 | CA2075974C Totally synthetic affinity reagents |
| 02/06/2001 | CA2067744C The human c3b/c4b receptor (cr1) |
| 02/06/2001 | CA2025491C Methods and materials for phe a feedback inhibition resistance |
| 02/06/2001 | CA2013544C Retinoblastoma gene product antibodies and uses therefor |
| 02/05/2001 | CA2311201A1 Ests and encoded human proteins |
| 02/05/2001 | CA2309313A1 Stimulation of the immune response by human dendritic cell manipulation |
| 02/03/2001 | CA2314466A1 Lentivirus from the group of immunodeficiency viruses of drill monkeys (mandrillus leucophaeus) and their use |
| 02/01/2001 | WO2001007917A1 Determining antibodies to ny-eso-1 in cancer patients |
| 02/01/2001 | WO2001007915A2 Layered device with capture regions for cellular analysis |
| 02/01/2001 | WO2001007898A1 Micro-array information display method |
| 02/01/2001 | WO2001007665A2 Sequence determination of nucleic acids using electronic detection |
| 02/01/2001 | WO2001007661A2 Polynucleotide amplification method |
| 02/01/2001 | WO2001007658A1 Abc transport polynucleotides, polypeptides, and antibodies |
| 02/01/2001 | WO2001007657A1 Peptide acceptor ligation methods |
| 02/01/2001 | WO2001007656A1 Antisense modulation of shp-1 expression |
| 02/01/2001 | WO2001007655A1 Antisense modulation of shp-2 expression |
| 02/01/2001 | WO2001007651A2 Transposon mediated differential hybridisation |
| 02/01/2001 | WO2001007647A2 Method for relative quantization of methylation of cytosin-type bases in dna samples |
| 02/01/2001 | WO2001007645A2 Method for marking solid, liquid and gaseous substances |
| 02/01/2001 | WO2001007641A2 Method for expressing a library of nucleic acid sequence variants and selecting desired traits |
| 02/01/2001 | WO2001007639A2 Selectable marker gene |
| 02/01/2001 | WO2001007637A2 Conditionally controlled, attenuated hiv vaccine |
| 02/01/2001 | WO2001007636A2 Maize dna ligase ii orthologue and uses thereof |
| 02/01/2001 | WO2001007635A1 Bs2 resistance gene |
| 02/01/2001 | WO2001007634A1 Method for increasing vitamin c content of plants |
| 02/01/2001 | WO2001007633A1 Novel system for the sequential, directional cloning of multiple dna sequences |
| 02/01/2001 | WO2001007632A1 Method for obtaining isogenic transgenic lines |
| 02/01/2001 | WO2001007631A2 Novel glycosyltransferase, the production thereof and its use |
| 02/01/2001 | WO2001007630A1 Novel cytochrome p450 monooxygenases and their use for oxidizing organic compounds |
| 02/01/2001 | WO2001007629A2 Dna sequences which code oygenases |
| 02/01/2001 | WO2001007628A2 Human synthetases |
| 02/01/2001 | WO2001007627A1 Drosophila recombination-associated protein and methods for use |
| 02/01/2001 | WO2001007626A2 Methods for producing l-amino acids by increasing cellular nadph |
| 02/01/2001 | WO2001007625A2 Ehrlichia canis genes and vaccines |
| 02/01/2001 | WO2001007624A2 Dna sequences which are suited for specifically detecting pseudomonas putida kt2440 |
| 02/01/2001 | WO2001007623A1 Epoxide hydrolases from streptomyces |
| 02/01/2001 | WO2001007622A2 DNA SEQUENCES THAT ENCODE TYPE II (xcp) SECRETION SYSTEMS |
| 02/01/2001 | WO2001007621A2 Dna sequences coding for abc transporters |
| 02/01/2001 | WO2001007620A1 Pyrf gene and the utilization thereof |
| 02/01/2001 | WO2001007619A1 Recombinant high molecular weight major outer membrane protein of moraxella |
| 02/01/2001 | WO2001007618A1 Homeobox genes encoding proteins participating in differentiation |
| 02/01/2001 | WO2001007616A1 Polynucleotide encoding autoantigens associated with endometriosis |
| 02/01/2001 | WO2001007615A1 PARASITIC HELMINTH DiAg2 PROTEINS, NUCLEIC ACID MOLECULES, AND USES THEREOF |
| 02/01/2001 | WO2001007614A1 Polynucleotides differentially expressed in adenocarcinomas, polypeptides encoded thereby, and methods of use thereof |
| 02/01/2001 | WO2001007613A2 Method for enhancing rna or protein production using non-native 5' untranslated sequences in recombinant viral nucleic acids |
| 02/01/2001 | WO2001007612A2 Receptors and associated proteins |